Program in Reproductive Endocrinology and Gynecology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; Shady Grove Fertility Center, Atlanta, Georgia; Fertility Science Consulting, Silver Spring, Maryland; Naval Medical Center, San Diego, California; Shady Grove Fertility Center, Mechanicsburg, Pennsylvania; and Shady Grove Fertility Center, Rockville, Maryland.
Corresponding author: M. Blake Evans, DO, Program in Reproductive Endocrinology and Gynecology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20814; email: [email protected].
Supported by the Division of Intramural Research: Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland.
Financial Disclosure Micah Hill served on the advisory board of and received personal fees from Ohana Biosciences. Kevin S. Richter disclosed that he was a paid consultant for EMD Serono. The other authors did not report any potential conflicts of interest.
Presented at the ACOG Armed Forces District Meeting, Honolulu, Hawaii, September 23–26, 2018, and at the American Society of Reproductive Medicine Conference, October 6–10, 2018, Denver, Colorado.
The views expressed in this manuscript are those of the authors and do not reflect the official policy or position of the Department of the Army, Department of Defense, or the U.S. Government.
Each author has confirmed compliance with the journal's requirements for authorship.
Peer reviews and author correspondence are available at https://links.lww.com/AOG/B809.
